Core Viewpoint - Ailong Technology's stock has shown a significant increase of 55.73% year-to-date, with a current market value of 1.646 billion yuan, indicating strong investor interest in the company's smart medical management solutions [1]. Group 1: Stock Performance - As of December 18, Ailong Technology's stock price rose by 2.01% to 21.32 yuan per share, with a trading volume of 604.37 million yuan and a turnover rate of 0.37% [1]. - The stock has experienced a slight increase of 0.42% over the last five trading days, but a decline of 4.99% over the past 20 days and 4.39% over the last 60 days [1]. Group 2: Company Overview - Ailong Technology, established on January 20, 2006, and listed on March 29, 2021, is located in the Suzhou Industrial Park, Jiangsu Free Trade Zone, focusing on intelligent management of medical supplies [1]. - The company's main business revenue breakdown includes: smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [1]. Group 3: Financial Performance - For the period from January to September 2025, Ailong Technology reported a revenue of 280 million yuan, reflecting a year-on-year growth of 25.12%, while the net profit attributable to shareholders was -959,000 yuan, showing a significant improvement of 96.56% year-on-year [2]. - The company has distributed a total of 111 million yuan in dividends since its A-share listing, with 49.05 million yuan distributed over the past three years [3]. Group 4: Shareholder Information - As of December 10, the number of Ailong Technology's shareholders decreased by 1.32% to 4,851, while the average circulating shares per person increased by 1.34% to 15,914 shares [2]. - As of September 30, 2025, the sixth largest circulating shareholder is Dazhong CSI 360 Internet + Index A, holding 741,700 shares, which is a decrease of 86,500 shares compared to the previous period [3].
艾隆科技涨2.01%,成交额604.37万元